( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Mohammed Abdelgader Elsheikh Mohammed*, Ameera Al-Haj Abu-Algassme Al-Ameen, Doaa Suliman Ibrahim Elfaki, Abrar Al-Khazeen, Sara Haroun Mohammed and Esra Muhammad Khamis


Background: Breast cancer continues to be a major cause of morbidity and mortality among Sudanese female population due to lack of education and efficient screening programs. Different parameters have been investigated to predict the prognosis in breast cancer; but still far from optimistic. E-cadherin is a novel prognostic marker which is a calcium-dependent epithelial cell adhesion molecule. Its loss has been associated with metastases, thereby plays a major role in histological grading of the cancer. The prognostic value of E-cadherin in breast cancer has been studied for years, yet results remain controversial. Aim: This study aimed to detect immunoexpression of E-cadherin in breast cancer tissues, and also to correlate expression of E-cadherin with tumor grade and patients age and to evaluate the prognostic and metastatic values of E- cadherin in breast cancer. Materials and methods: This was a descriptive cross sectional study conducted in Khartoum state-Sudan during period from December to July 2018. Forty three formalin fixed paraffin embedded (FFPE) tissues were included in this study; 39 tissues from patients with invasive ductal carcinoma and 4 tissues with invasive lobular carcinoma, were subjected to detect immunoexpression of E-cadherin in breast cancer tissues. Results: E-cadherin was lost in 79.1% expressed in 20.9% of cases (N=43). 82.1% of cases with Invasive Ductal Carcinoma (IDC) were showed negative expression (=39), 50% of cases with ILC were showed negative expression. E-cadherin (score zero and one) was observed in tumors with higher grades, E-cadherin (score zero and one) was more frequently observed in tumors with positive lymph node metastasis and vice versa. Conclusion: E-cadherin was lost in the majority of tissues, also was lost gradually with the progression of tumors and metastasis, there was statistically significance different with tumor grades but not with metastasis.

Keywords: E-cadherin, Breast cancer, IDC, ILC, TMA, Sudan.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2024 Issue has been Published, Kindly check it on


    MAY 2024 issue has been successfully launched on MAY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia